相关实验视频

Updated: May 23, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

心率降低与左心室逆向重塑和扩展性心肌病中的机制特定分子表型有关

Natasha L Altman¹, Edward A Gill¹, Rami Kahwash²

¹Division of Cardiology (N.L.A., E.A.G., L.K.M., J.A.W., A.K.-F., W.A.M., I.A.C., E.R.J., D.S., S.L.E., M.R.G.T., S.L.G., L.M., T.A.M., P.M.B., D.P.K., M.R.B.), University of Colorado Anschutz Medical Campus, Aurora.

Circulation. Heart failure

|March 7, 2025

概括

在非缺血性扩张性心肌病中使用 ivabradine 降低心率 (HR) 显著改善左心室喷射率 (LVEF),并诱导独特的分子变化. 这种HR的减少对于反向重塑至关重要,特别是当β抑制剂不足时.

科学领域:

心血管医学心血管医学
分子心脏病学分子心脏病学
药理学药理学是指药理学的学科.

背景情况:

心率 (HR) 通过可能涉及左心室重塑的机制影响心力衰竭的结果.
与HR变化相关的特定分子表型在人类心室肌肉中仍然不清楚.

研究的目的:

为了研究HR降低对左心室重塑和基因表达在非缺血性扩张性心肌病患者的影响.
确定用伊瓦布拉丁抑制HCN4通道是否可以诱导反向重塑并改变分子表型.

主要方法:

一项随机,双盲研究,涉及22名患有非胰岛症扩张性心肌病症的患者,这些患者对β阻塞不耐药.
患者接受了24周的伊瓦布拉丁 (HCN4通道抑制剂) 或安慰剂,以及β-阻断剂.
测量左心室喷射分数 (LVEF),并从内心肌活检分析心肌基因表达.

主要成果:

降低HR的患者 (用伊瓦布拉丁治疗) 显示LVEF显著增加 (29.4%至44.2%,P=0.0003).
"不变HR"组 (安慰剂或伊瓦布拉丁) 没有显著改善LVEF (26.6%至29.2%,P=0.28).
基因表达分析显示,在HR降低组中,有151个差异表达的基因,具有独特的心脏保护特征,与β阻断剂反应组不同.

结论:

通过艾瓦布拉丁的HCN4通道抑制实现的HR降低与非缺血性扩张性心肌病中大量的左心室逆向重塑有关.
如果不能降低HR,可能导致对反向改造的β-阻断剂治疗无反应.
通过伊瓦布拉丁减少HR,诱导心肌中独特的分子特征,这表明了新的治疗途径.

关键词:

心肌病,扩张心肌病,扩张心肌病.基因表达的基因表达方式心脏衰竭是因为心脏衰竭.心率是指心率是如何发生的.艾瓦布拉丁是Ivabradine的一种药物.神经调节素-1-1 的作用.腹腔的重塑腹腔的重塑

更多相关视频

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...